Skip to main content
KMDA
NASDAQ Life Sciences

Kamada Details Withholding Tax Procedures for $14.4M Cash Dividend

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$8.1
Mkt Cap
$465.49M
52W Low
$5.54
52W High
$9.35
52W Position info
46% above low
Off High info
13% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

KMDA sits 46% above its 52-week low of $5.54.

Summary

Kamada announced updated withholding tax procedures for its $14.4 million cash dividend, including provisions for reduced tax rates for eligible Nasdaq shareholders and exemptions for Israeli corporate shareholders.


Key Events · Financing and Capital Events · KMDA

  • Tax Ruling Obtained for Cash Dividend

    Kamada received a tax ruling from the Israel Tax Authority regarding the $0.25 per share cash dividend, totaling approximately $14.4 million, previously announced on March 11, 2026.

  • Reduced Withholding Tax for Eligible Shareholders

    Nasdaq shareholders residing in countries with a tax treaty with Israel may be eligible for a reduced Israeli withholding tax rate on their dividend, subject to specific terms and documentation.

  • Exemption for Israeli Corporate Shareholders

    Israeli corporate Nasdaq shareholders may qualify for an exemption from Israeli withholding tax on the dividend under the ruling's conditions.

  • Payment and Record Dates Confirmed

    The dividend is expected to be paid on April 7, 2026, to shareholders of record as of March 23, 2026.


Analysis · KMDA · Life Sciences

Kamada Ltd. has secured a tax ruling from the Israel Tax Authority, providing crucial details on withholding tax procedures for its previously announced $0.25 per share cash dividend. This ruling allows eligible Nasdaq shareholders from countries with tax treaties with Israel to potentially benefit from a reduced withholding tax rate, and Israeli corporate shareholders may be exempt. This clarification is important for investors to understand the net proceeds from the significant $14.4 million dividend.

At the time of this filing, KMDA was trading at $8.10 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $465.5M. The 52-week trading range was $5.54 to $9.35. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

KMDA - Latest Insights

KMDA
Jul 20, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $6.91
Real-time Price: $7.06 info
Change: +$0.150 (+2%) info
Market Cap: $407.322M info
KMDA
Jul 20, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $7.43
Real-time Price: $7.06 info
Change: -$0.370 (-5%) info
Market Cap: $407.322M info
KMDA
Jul 13, 2026, 7:46 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $7.12
Real-time Price: $7.06 info
Change: -$0.060 (-0.84%) info
Market Cap: $407.322M info
KMDA
Jun 01, 2026, 7:00 AM EDT
Filing Type: 6-K
Importance Score:
7
Price at Filing: $7.91
Real-time Price: $7.06 info
Change: -$0.850 (-11%) info
Market Cap: $407.322M info
KMDA
Jun 01, 2026, 7:00 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $7.99
Real-time Price: $7.06 info
Change: -$0.930 (-12%) info
Market Cap: $407.322M info